Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

Clinical trial NCT06265532 · COMPLETED

Trial details

NCT number: NCT06265532
Sponsor: Hal Chapman
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2024-02-07
Primary completion: 2026-01-08
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.